Hospital Universitario Arnau de Vilanova de Lleida Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Lleida Spain (1956)

Organization Overview

First Clinical Trial
2006
NCT00369096
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Hospital Arnau de Vilanova | Hospital Arnau de Vilanova de Lleida | Hospital Arnau de Vilanova (Lleida) | Hospital Arnau de Vilanova (Valencia) | Hospital Arnau Vilanova | Hospital Royo Vilanova | Hospital Royo Villanova | Hospital Universitari Arnau de Vilanova | Hospital Universitari Arnau de Vilanova de Lleida | Hospital Universitario Arnau de Vilanova | Hospital Universitario Arnau de Vilanova de Lleida. | Servicio de Nefrologia del Hospital Arnau de Vilanova (Lleida - Spain)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 4)

Atherosclerosis (Phase 4)

Breast Neoplasms (Phase 4)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Cardiovascular Diseases (Phase 4)

Colitis (Phase 4)

Colitis, Ulcerative (Phase 4)

Colorectal Neoplasms (Phase 2)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Kidney Diseases (Phase 4)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Peritoneal Diseases (Phase 2)

Rectal Neoplasms (Phase 2)

Stroke (Phase 4)

Ulcer (Phase 4)

Vomiting (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial APIs: 28